Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Radiother Oncol ; 118(2): 220-6, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26979264

ABSTRACT

BACKGROUND AND PURPOSE: Compensation for respiratory motion is needed while administering radiotherapy (RT) to tumors that are moving with respiration to reduce the amount of irradiated normal tissues and potentially decrease radiation-induced collateral damages. The purpose of this study was to test a new ventilation system designed to induce apnea-like suppression of respiratory motion and allow long enough breath hold durations to deliver complex RT. MATERIAL AND METHODS: The High Frequency Percussive Ventilation system was initially tested in a series of 10 volunteers and found to be well tolerated, allowing a median breath hold duration of 11.6 min (range 3.9-16.5 min). An evaluation of this system was subsequently performed in 4 patients eligible for adjuvant breast 3D conformal RT, for lung stereotactic body RT (SBRT), lung volumetric modulated arc therapy (VMAT), and VMAT for palliative pleural metastases. RESULTS: When compared to free breathing (FB) and maximal inspiration (MI) gating, this Percussion Assisted RT (PART) offered favorable dose distribution profiles in 3 out of the 4 patients tested. PART was applied in these 3 patients with good tolerance, without breaks during the "beam on time period" throughout the overall courses of RT. The mean duration of the apnea-like breath hold that was necessary for delivering all the RT fractions was 7.61 min (SD=2.3). CONCLUSIONS: This first clinical implementation of PART was found to be feasible, tolerable and offers new opportunities in the field of RT for suppressing respiratory motion.


Subject(s)
Apnea/physiopathology , Breast Neoplasms/radiotherapy , Breath Holding , Lung Neoplasms/radiotherapy , Pleural Neoplasms/radiotherapy , Radiotherapy Planning, Computer-Assisted/methods , Adult , Breast Neoplasms/diagnostic imaging , Feasibility Studies , Female , Humans , Lung Neoplasms/diagnostic imaging , Male , Middle Aged , Motion , Pilot Projects , Pleural Neoplasms/diagnostic imaging , Radiosurgery/methods , Radiotherapy, Conformal/methods , Radiotherapy, Intensity-Modulated/methods , Respiration , Tomography, X-Ray Computed
2.
J Nucl Med ; 57(3): 416-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26635339

ABSTRACT

UNLABELLED: Respiratory motion negatively affects PET/CT image quality and quantitation. A novel Pulsatile-Flow Ventilation (PFV) system reducing respiratory motion was applied in spontaneously breathing patients to induce sustained apnea during PET/CT. METHODS: Four patients (aged 65 ± 14 y) underwent PET/CT for pulmonary nodule staging (mean, 11 ± 7 mm; range, 5-18 mm) at 63 ± 3 min after (18)F-FDG injection and then at 47 ± 7 min afterward, during PFV-induced apnea (with imaging lasting ≥8.5 min). Anterior-posterior thoracic amplitude, SUVmax, and SUVpeak (SUVmean in a 1-cm-diameter sphere) were compared. RESULTS: PFV PET/CT reduced thoracic amplitude (80%), increased mean lesion SUVmax (29%) and SUVpeak (11%), decreased lung background SUVpeak (25%), improved lesion detectability, and increased SUVpeak lesion-to-background ratio (54%). On linear regressions, SUVmax and SUVpeak significantly improved (by 35% and 23%, respectively; P ≤ 0.02). CONCLUSION: PFV-induced apnea reduces thoracic organ motion and increases lesion SUV, detectability, and delineation, thus potentially affecting patient management by improving diagnosis, prognostication, monitoring, and external-radiation therapy planning.


Subject(s)
Lung Neoplasms/diagnostic imaging , Respiration, Artificial , Respiratory Mechanics , Aged , Apnea/diagnostic imaging , Apnea/physiopathology , Female , Fluorodeoxyglucose F18 , Humans , Image Processing, Computer-Assisted , Lung/diagnostic imaging , Lung Neoplasms/physiopathology , Male , Middle Aged , Motion , Positron-Emission Tomography , Predictive Value of Tests , Radiopharmaceuticals , Solitary Pulmonary Nodule/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...